Search company, investor...

PharmaSonics

Founded Year

1995

Stage

Unattributed VC | Alive

Total Raised

$27.7M

Last Raised

$5M | 21 yrs ago

About PharmaSonics

PharmaSonics is a Healthcare/Medical Devices & Equipment company based in Sunnyvale, California. PharmaSonics' investors include Institutional Venture Partners, Skyline Ventures, Sofinnova and Nikko Synergy Ventures.

Headquarters Location

1024 Morse Avenue

Sunnyvale, California, 94089,

United States

408-734-1914

Missing: PharmaSonics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PharmaSonics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

PharmaSonics Frequently Asked Questions (FAQ)

  • When was PharmaSonics founded?

    PharmaSonics was founded in 1995.

  • Where is PharmaSonics's headquarters?

    PharmaSonics's headquarters is located at 1024 Morse Avenue, Sunnyvale.

  • What is PharmaSonics's latest funding round?

    PharmaSonics's latest funding round is Unattributed VC.

  • How much did PharmaSonics raise?

    PharmaSonics raised a total of $27.7M.

  • Who are the investors of PharmaSonics?

    Investors of PharmaSonics include Institutional Venture Partners, Sofinnova Ventures, Goodman Co., Boston Scientific, Skyline Ventures and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.